Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family - PubMed (original) (raw)
Comparative Study
. 1995 Sep 15;310 ( Pt 3)(Pt 3):965-74.
doi: 10.1042/bj3100965.
Affiliations
- PMID: 7575434
- PMCID: PMC1135990
- DOI: 10.1042/bj3100965
Comparative Study
Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family
I McPhee et al. Biochem J. 1995.
Abstract
COS-7 cells were transfected with a plasmid encoding a putative splice variant of PDE4A cyclic AMP-specific phosphodiesterase, RPDE-6 (RNPDE4A5). This led to the expression of a novel, cyclic AMP-specific, rolipram-inhibited phosphodiesterase activity. In such transfected cells a novel approximately 109 kDa species was recognized by anti-peptide sera raised against a dodecapeptide whose sequence is found at the extreme C-terminus of both RPDE-6 and another PDE4A splice variant. RD1 (RNPDE4A1A). RPDE-6 activity and immunoreactivity was found distributed between both pellet (approximately 25%) and cytosol (approximately 75%) fractions of transfected COS-7 cells. Soluble and pellet RPDE-6 activities exhibited similar low Km values for cyclic AMP (approximately 2.4 microM) and were both inhibited by low concentrations of rolipram, with IC50 values for the soluble activity being lower (approximately 0.16 microM) than for the pellet activity (approximately 1.2 microM). Pellet RPDE-6 was resistant to release by either high NaCl concentrations or the detergent Triton X-100. Probing brain homogenates with the anti-(C-terminal peptide) sera identified two immunoreactive species, namely an approximately 79 kDa species reflecting RD1 and an approximately 109 kDa species that co-migrated with the immunoreactive species seen in COS cells transfected to express RPDE-6. The approximately 109 kDa species was found distributed between both the low-speed (P1) and high-speed (P2) pellet fractions as well as the cytosol fractions derived from both brain and RPDE-6-transfected COS cells. In contrast, RD1 was found exclusively in the P2 fraction. Phosphodiesterase (PDE) activity immuno-precipitated by these antisera from brain cytosol had the characteristics of COS cell-expressed RPDE-6 with KmcyclicAMP approximately 3.7 microM and IC50rolipram approximately 0.12 microM. The distribution of PDE activity immunoprecipitated from the cytosol of various brain regions paralleled that seen for the distribution of the approximately 109 kDa immunoreactive species. It is suggested that the 109 kDa species identified in brain cytosol and pellet fractions is the native form of RPDE-6. The PDE4A splice variants, RD1 and RPDE-6, were shown to have distinct patterns of expression among various brain regions. PDE4A and PDE4B activities appear to provide the major source of PDE4 activity in brain membranes, whereas the cytosolic PDE4 activity is suggested to reflect predominantly the activity of the PDE4D family. Alternative splicing of the PDE4A gene confers distinct N-terminal domains on RPDE-6 and RD1, which attenuates the Vmax. of these enzymes and defines their distinct subcellular distribution pattern.
Similar articles
- The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).
O'Connell JC, McCallum JF, McPhee I, Wakefield J, Houslay ES, Wishart W, Bolger G, Frame M, Houslay MD. O'Connell JC, et al. Biochem J. 1996 Aug 15;318 ( Pt 1)(Pt 1):255-61. doi: 10.1042/bj3180255. Biochem J. 1996. PMID: 8761480 Free PMC article. - Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3.
Huston E, Lumb S, Russell A, Catterall C, Ross AH, Steele MR, Bolger GB, Perry MJ, Owens RJ, Houslay MD. Huston E, et al. Biochem J. 1997 Dec 1;328 ( Pt 2)(Pt 2):549-58. doi: 10.1042/bj3280549. Biochem J. 1997. PMID: 9371714 Free PMC article. - Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase.
Houslay MD, Scotland G, Erdogan S, Huston E, Mackenzie S, McCallum JF, McPhee I, Pooley L, Rena G, Ross A, Beard M, Peder A, Begg F, Wilkinson I, Yarwood S, Ackerman C, Houslay ES, Hoffman R, Engels P, Sullivan M, Bolger G. Houslay MD, et al. Biochem Soc Trans. 1997 May;25(2):374-81. doi: 10.1042/bst0250374. Biochem Soc Trans. 1997. PMID: 9191121 Review. No abstract available. - Alternative splicing of the type-IVA cyclic AMP phosphodiesterase gene provides isoform variants with distinct N-terminal domains fused to a common, soluble catalytic unit: 'designer' changes in Vmax, stability and membrane association.
Houslay MD, Scotland G, Pooley L, Spence S, Wilkinson I, McCallum F, Julien P, Rena NG, Michie AM, Erdogan S, et al. Houslay MD, et al. Biochem Soc Trans. 1995 May;23(2):393-8. doi: 10.1042/bst0230393. Biochem Soc Trans. 1995. PMID: 7672427 Review. No abstract available.
Cited by
- Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2.
Sullivan M, Rena G, Begg F, Gordon L, Olsen AS, Houslay MD. Sullivan M, et al. Biochem J. 1998 Aug 1;333 ( Pt 3)(Pt 3):693-703. doi: 10.1042/bj3330693. Biochem J. 1998. PMID: 9677330 Free PMC article. - Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms.
Takahashi M, Terwilliger R, Lane C, Mezes PS, Conti M, Duman RS. Takahashi M, et al. J Neurosci. 1999 Jan 15;19(2):610-8. doi: 10.1523/JNEUROSCI.19-02-00610.1999. J Neurosci. 1999. PMID: 9880581 Free PMC article. - Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.
MacKenzie SJ, Yarwood SJ, Peden AH, Bolger GB, Vernon RG, Houslay MD. MacKenzie SJ, et al. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3549-54. doi: 10.1073/pnas.95.7.3549. Proc Natl Acad Sci U S A. 1998. PMID: 9520403 Free PMC article. - Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells.
Owens RJ, Catterall C, Batty D, Jappy J, Russell A, Smith B, O'Connell J, Perry MJ. Owens RJ, et al. Biochem J. 1997 Aug 15;326 ( Pt 1)(Pt 1):53-60. doi: 10.1042/bj3260053. Biochem J. 1997. PMID: 9337850 Free PMC article. - Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
MacKenzie SJ, Baillie GS, McPhee I, MacKenzie C, Seamons R, McSorley T, Millen J, Beard MB, van Heeke G, Houslay MD. MacKenzie SJ, et al. Br J Pharmacol. 2002 Jun;136(3):421-33. doi: 10.1038/sj.bjp.0704743. Br J Pharmacol. 2002. PMID: 12023945 Free PMC article.
References
- J Biol Chem. 1993 Mar 25;268(9):6470-6 - PubMed
- J Cell Biol. 1992 Feb;116(3):799-807 - PubMed
- Biochem J. 1993 Jun 15;292 ( Pt 3):677-86 - PubMed
- Mol Cell Biol. 1993 Oct;13(10):6558-71 - PubMed
- J Biol Chem. 1994 Jan 7;269(1):347-57 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources